finmarketnews.com
news-details
Health,Health Technology,Health Services,Watchlist

4 HealthTech Stocks up over 63% past 10 days (BVS stock, MBOT stock, AUTL stock, RXRX stock)

Today, the screeners at HealthTechMovers.com picked up 4 HealthTech Stocks up over 63% past 10 days and have been added to our watchlist.  These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.

FinMarketNews.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.

One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com. 

 

Bioventus, BVS
Summary: Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.
Recent BVS Stock Price (approx 10:00am EST.): $2.72
Previous Close for BVS Stock: $2.56
Percentage Price Change Past 10 Days for BVS stock: +149% 

TipRanks.com reports that Bioventus stock currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating for BVS stock with an average price target is $2.50. 

Click here to get the full story on BVS stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Microbot Medical, MBOT
Summary: Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. 
Recent MBOT Stock Price (approx 10:00am EST.): $2.01
Previous Close for MBOT Stock: $1.91
Percentage Price Change Past 10 Days for MBOT stock: +80% 

TipRanks.com reports that Microbot Medical stock currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for MBOT stock with an average price target is $8.00. 

Click here to get the full story on MBOT stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Autolus Therapeutics, AUTL
Summary: Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies. The company's pipeline of product candidate involved in development for the treatment of haematological malignancies and solid tumours. Autolus Therapeutics plc is based in London, United Kingdom.
Recent AUTL Stock Price (approx 10:00am EST.): $3.17
Previous Close for AUTL Stock: $3.11
Percentage Price Change Past 10 Days for AUTL stock: +63% 

TipRanks.com reports that Autolus Therapeutics stock currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for AUTL stock with an average price target is $7.50. 

Click here to get the full story on AUTL stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Recursion Pharmaceuticals, RXRX
Summary: Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.
Recent RXRX Stock Price (approx 10:00am EST.): $9.17
Previous Close for RXRX Stock: $8.96
Percentage Price Change Past 10 Days for RXRX stock: +63% 

TipRanks.com reports that Recursion Pharmaceuticals stock currently has 6 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for RXRX stock with an average price target is $15.00. 

Click here to get the full story on RXRX stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------


Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com.

The other great tool for charting is TradingView.com, so you might want to check that out too.

The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.

FinMarketNews.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinMarketNews.com.